Dr. Jacqueline Saw is an interventional cardiologist and the Director of the Interventional Cardiology Fellowship Program at Vancouver General Hospital, in addition to being a clinical professor in the Division of Cardiology at the University of British Columbia. She is a leader in the research and treatment of a condition called spontaneous coronary artery dissection (SCAD) which predominantly affects young, healthy women without traditional cardiac risk factors. Her other research interests include left-atrial appendage (LAA) closure, percutaneous coronary intervention (PCI), carotid artery stenting, peripheral arterial disease and intervention, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia) and antiplatelet therapy. Her clinical expertise has led her to serve as the physician proctor for LAA closure using the Amplatzer Amulet and WATCHMAN devices globally.
Dr. Saw obtained her medical degree at the University of Ottawa and completed residencies in internal medicine and cardiology at the University of British Columbia, during which she held the title of chief cardiology fellow. She went on to complete a fellowship in interventional cardiology at the Cleveland Clinic Foundation, where she received advanced training on the treatment of carotid, peripheral and structural pathologies. As a proponent of research, Dr. Saw is the principal investigator for several high-profile projects including the Canadian Institutes of Health Research (CIHR) funded SCAD study. She has authored over 300 peer-reviewed publications and is the editor of three textbooks on carotid artery stenting and LAA closure.
She currently serves as an associate editor for the Journal of the American College of Cardiology: Cardiology Interventions.
